Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma Patients
NCT ID: NCT02737800
Last Updated: 2018-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
88 participants
INTERVENTIONAL
2016-04-30
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trans-vaginal Aspiration of Small Ovarian Endometrioma. Comparison of Two Different Techniques Before ICSI
NCT03784404
Role of Medical Treatment in Endometriosis Patients Undergoing ICSI
NCT06577974
Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Women With Endometriosis
NCT02470169
Effect of Endometrial Injury in Couples With Unexplained Infertility
NCT03398993
Surgery and ART For Endometrioma
NCT03717870
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Group 1A;Cyst aspiration followed by standard long protocol in 15 patients Group 1B;Cyst aspiration followed by GnRh suppression for 3 months then standard long protocol in 15 patients
Group 2 consists of 30 patients of endometrioma less than 5cm subdivided into :
Group 2A;no intervention to the cyst. Standard long protocol Group 2B;GnRh suppression for 3 months then standard long protocol
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1A endometrioma more than 5cm
Endometrioma aspiration GnRh agonist :Decapeptyl 3.75mg intramuscular Standard long stimulation protocol \& ICSI
endometrioma aspiration
Transvaginal ultrasound guided aspiration
GnRh agonist ( Decapeptyl )
3 monthly doses of Decapeptyl 7.5mg intramuscular
standard long stimulation protocol
Decapeptyl 3.75mg in the mid luteal phase followed by human menopausal gonadotropins(HMG);fostimon, or merional injections after bleeding, doses are individualization according to each patient, monitored by follicular size \&serum estradiol.
1B endometrioma more than 5cm control
Endometrioma aspiration Standard long stimulation protocol \& ICSI
endometrioma aspiration
Transvaginal ultrasound guided aspiration
standard long stimulation protocol
Decapeptyl 3.75mg in the mid luteal phase followed by human menopausal gonadotropins(HMG);fostimon, or merional injections after bleeding, doses are individualization according to each patient, monitored by follicular size \&serum estradiol.
2A endometrioma less than 5cm
Decapeptyl 3.75mg intramuscular Standard long stimulation protocol \& ICSI
GnRh agonist ( Decapeptyl )
3 monthly doses of Decapeptyl 7.5mg intramuscular
standard long stimulation protocol
Decapeptyl 3.75mg in the mid luteal phase followed by human menopausal gonadotropins(HMG);fostimon, or merional injections after bleeding, doses are individualization according to each patient, monitored by follicular size \&serum estradiol.
2B endometrioma less than 5cm control
Standard long stimulation protocol \& ICSI
standard long stimulation protocol
Decapeptyl 3.75mg in the mid luteal phase followed by human menopausal gonadotropins(HMG);fostimon, or merional injections after bleeding, doses are individualization according to each patient, monitored by follicular size \&serum estradiol.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
endometrioma aspiration
Transvaginal ultrasound guided aspiration
GnRh agonist ( Decapeptyl )
3 monthly doses of Decapeptyl 7.5mg intramuscular
standard long stimulation protocol
Decapeptyl 3.75mg in the mid luteal phase followed by human menopausal gonadotropins(HMG);fostimon, or merional injections after bleeding, doses are individualization according to each patient, monitored by follicular size \&serum estradiol.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* hydrosalpinx
* GnRh suppression in the last 12 months
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kasr El Aini Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
suzy abdelaziz Abdelhamid
lecturer of obgyn.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
suzy abdelaziz, lecturer
Role: PRINCIPAL_INVESTIGATOR
Kasr El Aini Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kasrelaini Hospital
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
obgynivf
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.